- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Norwegian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
1
0 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
VISTN | NOK 23.60 | -1.7% | 0.4% | NOK 1.0b | n/a | PE17.1x | n/a | 4.2% |
Page 1 of 1